Does Using a Mandibular Advancement Device with Bruxism Cause TMJ Problems?

A mandibular advancement device (MAD) is a custom oral appliance that holds your lower jaw (mandible) in a protruded position during sleep. By advancing the jaw forward, it tightens the soft tissue and muscles around the airway, reducing the collapse that produces snoring and the airway obstruction that defines obstructive sleep apnea (OSA).

Most MADs are titratable, meaning they can be adjusted over weeks to find the minimum advancement that controls airway obstruction without creating excessive strain on the joints and muscles. The therapeutic range is typically 50 to 75 percent of your maximum protrusive movement, though the ideal position varies by individual anatomy.

The forward jaw position is maintained throughout the night. This is a prolonged, sustained load on the temporomandibular joints, the muscles of mastication, and the ligaments of the joint capsule. For patients with healthy joints and no significant bruxism, this load is usually well tolerated.

Bruxism during sleep generates compressive and shear forces on the condyle that far exceed those of normal chewing. When you grind or clench, the masseter and temporalis muscles contract powerfully, pressing the condyle into the joint fossa. The interposed disc and retrodiscal tissue absorb this force. Over time, repeated overloading damages disc tissue and inflames the joint capsule.

When bruxism co-occurs with MAD use, the problem compounds. The jaw is held protruded (shifting condyle position relative to the fossa) while the muscles simultaneously generate high compressive force. The disc, which is already displaced slightly by the protrusion, faces load in a geometry it is not designed for. The retrodiscal tissue, which is highly vascular and pain-sensitive, bears more of the force.

Research data are mixed, but multiple studies have found that bruxers who use MADs have higher rates of jaw muscle soreness, TMJ pain, and bite changes than non-bruxers using the same devices. This is not a reason to automatically rule out MAD therapy for bruxers, but it is a reason to evaluate the joint before initiating treatment.

Pre-existing disc displacement is the most significant risk factor. If the disc is already displaced anteriorly (forward) and only partially reduces on opening, adding nightly protrusion can push it further out of position. Over months, this can convert a partially displaced disc into a fully displaced, non-reducing disc, which is associated with persistent pain and limited opening.

Condylar bone changes visible on CBCT, such as flattening, erosion, or osteophytes, indicate that the joint has already sustained significant loading damage. A joint in this state has less capacity to adapt to the additional stress of MAD-induced protrusion.

Hypermobility of the joint (the condyle traveling farther forward than normal on opening) suggests ligamentous laxity. In these patients, a MAD can produce excessive protrusion relative to what the joint tolerates, even at a modest advancement setting.

Muscle hypertonicity, meaning muscles that are persistently tense and tender on palpation, signals that the system is already near its load tolerance. Adding sustained protrusion to an already overworked masseter or medial pterygoid often tips the balance into symptomatic pain.

Bruxism alone is not a contraindication to MAD therapy. Patients who brux but have healthy joints, no disc displacement, and no bone changes on imaging can often use a MAD successfully with careful titration and monitoring. The key is baseline assessment before device delivery, not assumption.

Mild to moderate OSA that has not responded to or is not tolerated by CPAP is a legitimate indication for MAD therapy. Sleep apnea carries significant cardiovascular risk, and that risk must be weighed against the risk of joint strain. For many patients, the OSA risk outweighs the TMJ risk, particularly if joint health is good.

Starting at a conservative advancement (50 percent or less of maximum protrusion) and titrating slowly over weeks gives the joint time to adapt and gives you time to identify soreness before it becomes persistent. A device that works at 60 percent advancement with no symptoms is better than one at 70 percent with daily morning jaw ache.

A combined splint approach is used in some cases: a lower MAD to advance the airway combined with a flat occlusal surface design to reduce the bite-change effects of prolonged protrusion. This is more involved to fabricate but reduces some of the jaw repositioning effects seen with simpler device designs.

Morning jaw soreness is the most common early signal. Mild soreness that resolves within 30 minutes of removing the device and doing gentle opening exercises is usually tolerable, especially in the first few weeks of use. Soreness that persists for hours, that does not improve with time, or that is worsening week over week is a sign to reduce advancement or pause use.

Changes in your bite are a well-documented side effect of long-term MAD use. Many patients notice that their back teeth no longer meet as firmly as before, or that their front teeth contact more than usual. This occurs because the mandible repositions in response to months of nightly protrusion. These changes are usually small and often reversible, but they should be monitored with periodic dental check-ins.

New clicking, locking, or sharp joint pain are signals that warrant stopping use and getting a clinical evaluation before resuming. These symptoms suggest the disc or joint capsule is being stressed beyond its tolerance.

Prescribing a MAD without a TMJ evaluation is a common oversight, particularly when devices are delivered through online services or without imaging. The assumption that a custom-fitted device is inherently safe overlooks the fact that device design and advancement level need to be calibrated to the state of your joint.

A TMJ evaluation before MAD therapy should include palpation of the joint and muscles, measurement of opening range, and some form of imaging if there are any symptoms or risk factors. This baseline lets the clinician set appropriate expectations, choose a conservative starting advancement, and identify warning signs quickly if they develop.

At KYT Dental Services, patients who are considering or already using an oral appliance for sleep-disordered breathing have the option to have their joint assessed as part of the evaluation, so that device therapy and joint health are managed together rather than separately.